J. M. Salmasi

J. M. Salmasi

Auto-generated profile, based on publicly available information

J. M. Salmasi

Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
IKI. V. Kukes
I. V. Kukes
JSJ. M. Salmasi
J. M. Salmasi
KTK. S. Ternovoy
K. S. Ternovoy
АKАlexander Kazimirskii
Аlexander Kazimirskii
TOT. E. Obodzinskaya
T. E. Obodzinskaya
AAA. D. Andreev
A. D. Andreev
SARS-CoV-2 is a novel coronavirus that has been identified as the cause of the 2019 coronavirus infection (COVID-19), which originated at Wuhan city of PRC in late 2019 and widespread worldwide. As the number of patients recovering from COVID-19 continue to grow, it’s very important to understand what health issues they may keep experiencing. COVID-19 is now recognized as an infectious disease that can cause multiple organ diseases of various localization. It is against this background that a new term was introduced: post-acute post-COVID-19 syndrome characterized by several persistent symptoms inherent in the acute phase of the disease, as well as the occurrence of delayed and (or) long-term complications beyond 4 weeks from the onset of the disease. The work reflected in this article revealed a portrait of a patient with post-COVID-19 syndrome, the most common complications of this period, as well as the mechanisms of their development and the resulting metabolic, cellular, tissue disorders leading to the tissue and organ dysfunctions. A comprehensive biochemical and immunological screening was carried out using the example of three clinical cases to identify the most significant disorders in these patients and to correlate with their clinical status over time. In point of fact, such patients were diagnosed with vascular dysfunction factors (development of endothelial dysfunction), metabolic dysfunction factors (metabolic acidosis, mitochondrial dysfunction, carbohydrate metabolism disorder, insulin resistance, altered branched-chain and aromatic amino acid metabolism), neurological disorder factors (neurotoxicity of the resulting metabolites), immunological disorder factors (decreased efficiency of detoxification systems, secondary immunodeficiency, risk of secondary bacterial infection).

21 September 2020 in Bulletin of Russian State Medical University
Verified
Journal Article
Closed access
АKАlexander Kazimirskii
Аlexander Kazimirskii
JSJm Salmasi
Jm Salmasi
GPGv Poryadin
Gv Poryadin
Antiviral system of innate immunity includes two main components: the mitochondrial antiviral sensor — the mitochondrial outer membrane protein and peripheral blood neutrophils capable of forming neutrophilic extracellular traps. Depending on the activation pathway of the mitochondrial antiviral sensor (MAVS), two possible variants of cells death, apoptosis or cellular degeneration with necrotic changes, develop during cell infection with an RNA-containing virus. The development of virus-induced apoptosis of infected cells causes the formation of neutrophilic extracellular traps, the secretion of inflammatory cytokines, ROS generation, tissue damage, hemocoagulation and the development of an acute inflammatory process with the development of COVID-19 pneumonia. Violation of the prion-like reaction of MAVS in response to viral infection of the cell triggers an alternative pathway for activating autophagy. Cells under conditions of prolonged activation of autophagy experience necrotic changes and are eliminated from the organism by monocytes/macrophages that secrete anti-inflammatory cytokines. This type of reaction of the antiviral system of innate immunity corresponds to the asymptomatic course of the disease. From the most significant aspects of the pathogenesis of the coronavirus infection COVID-19 given, recommendations for the prophylactic treatment of this dangerous disease follow. The proposed treatment can significantly decrease the severity of COVID-19 disease and reduce mortality.

16 July 2022 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
АKАlexander Kazimirskii
Аlexander Kazimirskii
JSJ. M. Salmasi
J. M. Salmasi
GPG. V. Poryadin
G. V. Poryadin
MPM. I. Panina
M. I. Panina
Vera LarinaVera Larina
Vera Larina
ARA. A. Ryzhikh
A. A. Ryzhikh
Post-COVID syndrome is characterized by fatigue, reduced exercise tolerance, muscle and joint pain, and psychoemotional disorders. In the development of a generalized body response in a viral infection, abnormal defense responses are of great importance. We studied neutrophils, neutrophil extracellular traps (NETs), DNA degradation products (purine nitrogenous bases, PNBs), and traditional biochemical parameters.Aim. To determine biochemical parameters and the number of NETs and PNBs in the peripheral blood of patients with post-COVID syndrome.Materials and methods. The study included outpatients (n = 21) aged 18–59 years (36 [27 ÷ 50]). The control group consisted of 20 individuals aged 18–59 years (38.5 [29 ÷ 51.5]) without a past medical history of the coronavirus infection. All patients underwent a physical examination, their medical history was assessed, and the level of NETs and PNBs in the venous blood was determined.Results. 11 patients had a mild form of the disease in their past medical history, 7 – moderate, and 3 – severe. The most common symptoms in the patients were fatigue, headache, epigastric pain, dizziness, and joint pain. Hair loss and dyspnea were less common. The concentration of NETs and PNBs was higher in the patients with post-COVID syndrome than in the control group (p < 0.05). We detected NETs in the patients with post-COVID syndrome only in the form of filamentous structures. The concentration of extracellular purine bases in the blood of the patients with post-COVID syndrome was the highest in patients with moderate and severe acute periods. In patients with a mild acute period, the concentration of PNBs was 7.38 [0.0 ÷ 60.7] mg / ml, and in patients with moderate and severe acute periods – 19.15 [0.0 ÷ 33.5] and 34.19 [3.35 ÷ 70.0] mg / ml, respectively.Conclusion. Extracellular purine bases in concentrations capable of causing secondary alteration of cells are found in the peripheral blood of patients with post-COVID syndrome. Post-COVID syndrome is accompanied by the formation of filamentous NETs in the blood of patients.

25 November 2022 in Koloproktologia
Verified
Journal Article
Open access
PDF file
OFO. Yu. Fomenko
O. Yu. Fomenko
SMSergey Morozov
Sergey Morozov
YSYu. A. Shelygin
Yu. A. Shelygin
DND. B. Nikityuk
D. B. Nikityuk
GPG. V. Poryadin
G. V. Poryadin
SASergey I. Achkasov
Sergey I. Achkasov
This paper presents interdisciplinary consensus on the use of protocols of high-intensity magnetic stimulation for the treatment of pelvic floor muscles dysfunction with anal incontinence in Russia.AIM: to highlight the discussion and the decision-making on the basis of an interdisciplinary consensus on the use of a new algorithm of peripheral and transcranial magnetic stimulation in the treatment of pelvic floor muscles dysfunction with the clinic of anal incontinence.RESULTS: the adoption of this consensus can serve as a basis for further research of this problem and optimize the results of treatment of patients with pelvic floor muscle dysfunction with anal incontinence. The data may be interesting for a wide range of medical specialists: general practitioners, gastroenterologists, coloproctologists, surgeons, neurosurgeons, gynecologists, urologists — anyone who encounter with manifestations of this disorder in a routine practice and chooses diagnostic and treatment options.CONCLUSION: protocols for the treatment of anal incontinence using high-intensity magnetic stimulation aimed at improving the quality of treatment of patients with anal incontinence are based on the Russian experience of using the methods discussed and the analysis of the results obtained are validated.

10 April 2024 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
АKАlexander Kazimirskii
Аlexander Kazimirskii
JSJ. M. Salmasi
J. M. Salmasi
GPG. V. Poryadin
G. V. Poryadin
MPM. I. Panina
M. I. Panina
VSViktor Александрович Stupin
Viktor Александрович Stupin
LRL. S. Rogozhina
L. S. Rogozhina
Background. Neutrophil extracellular traps (NETs) are net-like structures that have been investigated in inflammatory diseases. However, the presence of NETs in infected persons without clinical symptoms has not been yet studied.Aim. To reveal NETs in healthy persons during and after the H1N1 influenza pandemic as well as to study the functional activity of NETs.Materials and methods. The study included two groups of volunteers (n = 10 in each group) aged 20–25 years. The first group of volunteers was examined in the absence of acute diseases during one month before the study and in the absence of chronic diseases in the medical history. Volunteers of the second group were in contact with patients with influenza, but did not get sick. The comparative study also included patients with acute inflammation in the abdominal cavity (appendicitis, cholecystitis, abscess; 12 patients) and 9 patients with non-specific ulcerative colitis. Neutrophils were isolated from the blood by the traditional method of Ficoll density centrifugation. The number, morphology, and functional activity of NETs were determined (by capture of Klebsiella pneumoniae). SYBR Green I-based fluorescence microscopy was used to visualize and quantify NETs.Results. In healthy volunteers who were not in contact with infected patients, spontaneous NETs formation did not occur. Neutrophils of persons who were in contact with infected patients spontaneously formed NETs. In this case the number of NETs reached 8.58 ± 0.51%, and the size of NETs amounted to 39.68 ± 3.52 µm. NETs effectively captured cells of the tested microorganism, which was accompanied by retraction of network fibers and transformation of the network structure into a cloud-like one, which retained 89.38 ± 5.86 microbial cells. For comparison, the NETs in patients with acute inflammation in the abdominal cavity captured and bound 20.2 ± 1 .67 microbial cells and with non-specific ulcerative colitis – 5.53 ± 0.34 cells.Conclusion. High binding capacity of NETs is a factor contributing to effective defense of the body against the development of an infectious disease with manifested clinical symptoms.

12 August 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
АKАlexander Kazimirskii
Аlexander Kazimirskii
JSJ. M. Salmasi
J. M. Salmasi
GPG. V. Poryadin
G. V. Poryadin
IKI. V. Kukes
I. V. Kukes
Abstract Introduction.Considering the development of technologies and techniques, it is highly relevant today to continue studying the features of interaction of drugs developed and introduced into clinical practice in the 1960s and 1980s with the elements of the immune system located in the mucosa, since many of these drugs have local dosage forms. One such drug is benzidamine hydrochloride, registered as a nonsteroidal anti-inflammatory drug with extended pharmacodynamic properties.Objective. To evaluate the effect of benzidamine hydrochloride preparation on the cells of innate and acquired immunity located in the mucosa in an in vitro model.Materials and Methods. Cell fractions of neutrophils isolated from patients with infectious inflammation were used in the study. Sterile isolated neutrophils from the venous blood of patients were transferred into RPMI-1640 medium, where the investigated pharmacological drug was added, and incubation with cells was performed. Fluorescence microscopy was used to detect and count neutrophil extracellular traps. Cell fractions of lymphocytes isolated from patients with infectious inflammation were also used in the study. A commercial drug containing benzidamine hydrochloride, Tantum Verde (Angelini Pharma S.p.a., Italy), was used in the study.Results and discussion. Benzidamine causes significant inhibition of neutrophil extracellular trap formation. This suggests that at the beginning of application the drug enhances the antimicrobial response of the body, and then as the concentration decreases it demonstrates classic anti-inflammatory properties. The drug also enhances the neutrophil extracellular trap structure. The total number of B-lymphocytes tends to normalize under the effect of benzidamine. These data allow us to conclude about the ability of the drug to attenuate the severity of the inflammatory process, apparently by inhibiting the action of inflammatory cytokines.Conclusion.In the course of the in vitro study it was shown that benzidamine hydrochloride (Tantum Verde) has immunomodulatory properties against innate immunity cells – neutrophils, and its anti-inflammatory properties against adaptive immunity cells – lymphocytes – were confirmed.